ClonOrgan Biotechnology
PrivateLast Round
Series A
Extension
Sep 5, 2025
Total Funding Raised
$8.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ClonOrgan Biotechnology is a biotechnology company that specializes in the research and development of xenotransplantation technologies, including the breeding of gene-edited donor pigs for organ and tissue transplantation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ClonOrgan Biotechnology Comparables
Compare ClonOrgan Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Makana Therapeutics | 78% | |
| eGenesis | 78% | |
| Qihan Biotech | 74% | |
ClonOrgan Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Sep 5, 2025 | ||||
| Series A Extension | Jul 4, 2024 | ||||
| Series A | Sep 2, 2021 | ||||
| Early Funding | Dec 1, 2020 | ||||
| Angel | Oct 1, 2018 |
ClonOrgan Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Shenzhen Sangel Venture Capital | Angel |
| YuanBio Venture Capital | Series A Extension |
| Lightspeed China Partners | Series A Extension |
| Luminous Ventures | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 5, 2025
Led by Lightspeed China Partners with participation from Luminous Ventures and YuanBio Venture Capital.
ClonOrgan Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ClonOrgan Biotechnology's valuation, stock price, and market status.